太猛了！2026年首月新基金募资高达1202亿元：权益类霸屏，外资公募杀入前十

Core Insights - The A-share market continued its upward trend in January 2026, with the Shanghai Composite Index rising by 3.76% for the month [1] - The new fund issuance market experienced a "good start," with a total of 123 new funds established, raising a total of 120.2 billion yuan, an increase of over 30 billion yuan compared to the same period in 2025 [1] - Equity funds dominated the issuance, contributing over 60% of the total fundraising, with notable performances from several funds [1] Fund Issuance Overview - The top-performing fund in January was the GF Research Selected Mixed Fund, which raised 7.221 billion yuan, becoming the first equity fund to exceed 7 billion yuan in 2026 [2] - Other significant funds included the Hua Bao Advantage Industry Mixed Fund and the Morgan Stanley Hu-Shen-Hong Kong Technology Mixed Fund, raising 5.777 billion yuan and 4.424 billion yuan, respectively [2] - Fund of Funds (FOF) also gained traction, with 12 new FOFs launched, accounting for about 20% of the total new issuance [1][2] Fund Management Competition - A total of 59 institutions successfully launched new funds in January, with GF Fund leading the fundraising with 15 billion yuan, followed by ICBC Credit Suisse and E Fund with 8 billion yuan and 7.2 billion yuan, respectively [2][3] - The strong performance of foreign asset management firms, such as Morgan Stanley and Fidelity, added a new dynamic to the competitive landscape [2] Future Outlook - The momentum in new fund issuance is expected to continue into February, with 31 new funds set to launch in the first week, primarily focusing on equity funds [3] - Active equity products will include thematic funds like the Shangyin Medical Selected Fund and the GF Medical Innovation Selected Fund, while passive index products will target popular sectors such as biotechnology and non-ferrous metals [3]